Fernando Reyes and Ignacio Pérez-Victoria, from the Chemistry Department of MEDINA, attended the V GQB Chembio Group Meeting celebrated in Granada from the 19th to the 21st of February. Both presented recent results on the combined use of NMR and other chemistry-based...
MEDINA is leader in Drug Discovery from Microbial Natural Product Libraries and internal High Throughput Screening (HTS) programs are focused on strategic therapeutic areas: Infectious and Parasitic Diseases, Oncology and Neurodegeneration.
We are partners in European research networks and consortia in diverse areas of drug discovery and applied biotechnology.
MEDINA offers Contract Research services for Drug Discovery and other high value biotechnology areas to academic research and industrial organizations.
MEDINA discovers bio-active molecules, drug leads for unmet medical needs and high value biotechnological products.
We are exclusive owners of one of the world´s largest Microbial Collections (190,000 microbial strains), and Natural Products Libraries (over 135,000 extracts & fractions).
SUBSCRIBE TO OUR NEWSLETTER
LISSA Project: Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on surfaces.
Fundación MEDINA participates in the LISSA project, Alternatives to the use of disinfectants in the food industry aimed at reducing the survival of Listeria monocytogenes and Salmonella enterica on the surfaces, coordinated by Dr. Joaquín Venancio Martínez Suárez of...
Dr. Freddie Annang, specialist in parasitic diseases, attended the 12th Convention of Biomedical Research of Ghana from the 30th of July to the 1st of August to discuss Fundación MEDINA’s microbial library, infrastructure and professional expertise for possible...